INFLUENCE OF AGE, SEX AND BODY-WEIGHT ON THE DAPSONE ACETYLATION PHENOTYPE

被引：27

作者：

PHILIP, PA

GAYED, SL

ROGERS, HJ

CROME, P

机构：

[1] GUYS HOSP, UNITED MED & DENT SCH, DIV CLIN PHARMACOL, LONDON SE1 9RT, ENGLAND

[2] ORPINGTON HOSP, DEPT GERIATR MED, ORPINGTON BR6 9JU, KENT, ENGLAND

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1987年 / 23卷 / 06期

关键词：

D O I：

10.1111/j.1365-2125.1987.tb03105.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：709 / 713

页数：5

共 23 条

[1]

AHMAD RA, 1981, THESIS U LONDON

[2]

BUCHANAN N, 1979, S AFR MED J, V56, P299

[3]

CARR K, 1978, BRIT J CLIN PHARMACO, V6, P421, DOI 10.1111/j.1365-2125.1978.tb04606.x

[4]

CARTWRIGHT RA, 1982, LANCET, V2, P842

[5] POTENTIAL INFLUENCE OF BODY-WEIGHT ON THE CLEARANCE OF POLYMORPHICALLY ACETYLATED DRUGS [J].

CHAPRON, DJ ;

KRAMER, PA ;

MERCIK, SA .

JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 22 (5-6) :271-275

[6] GENETICALLY-DETERMINED VARIABILITY IN ACETYLATION AND OXIDATION - THERAPEUTIC IMPLICATIONS [J].

CLARK, DWJ .

DRUGS, 1985, 29 (04) :342-375

[7]

EVANS DA, 1961, B JOHNS HOPKINS HOSP, V108, P60

[8] SURVEY OF THE HUMAN ACETYLATOR POLYMORPHISM IN SPONTANEOUS DISORDERS [J].

EVANS, DAP .

JOURNAL OF MEDICAL GENETICS, 1984, 21 (04) :243-253

[9] GENETIC CONTROL OF ISONIAZID METABOLISM IN MAN [J].

EVANS, DAP ;

MANLEY, KA ;

MCKUSICK, VA .

BRITISH MEDICAL JOURNAL, 1960, 2 (AUG13) :485-491

[10] HEPATIC DRUG ACETYLATION AND OXIDATION - EFFECTS OF AGING IN MAN [J].

FARAH, F ;

TAYLOR, W ;

RAWLINS, MD ;

JAMES, O .

BRITISH MEDICAL JOURNAL, 1977, 2 (6080) :155-156

← 1 2 3 →